CXAI
CXApp Inc.
There isn't enough reported data to score CXAI yet.
INTC
Intel Corporation
INTC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
CXAI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Unavailable | |
| Strong |
CXAI's revenue and balance sheet are currently strong, but its profitability is under pressure. There isn't enough data to rate its cash flow.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
CXAI PE Valuation
CXAI has no meaningful PE right now: it lost money over the past year.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
CXAI Forward outlook
There aren't enough analyst estimates for CXAI to show an outlook.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
CXAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$21.35 | +$9.65 |
| Q2 2026 | -$26.50 | +$14.00 |
| Q1 2026 | -$29.50 | +$20.00 |
| Q4 2025 | -$29.00 | +$33.50 |
| Q3 2025 | -$31.00 | +$135.50 |
| Q2 2025 | -$40.50 | +$103.50 |
| Q1 2025 | -$49.50 | +$120.00 |
| Q4 2024 | -$62.50 | +$105.50 |
CXAI has the edge over INTC on earnings, with more consistent year-over-year improvement.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
CXAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3M | +170% |
| Q2 2026 | $1.7M | +39% |
| Q1 2026 | $950K | -22% |
| Q4 2025 | $1M | -38% |
| Q3 2025 | $1.1M | -41% |
| Q2 2025 | $1.2M | -31% |
| Q1 2025 | $1.2M | -33% |
| Q4 2024 | $1.7M | -3.4% |
CXAI's revenue is growing: $3M last quarter, up 170% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -105% | +238 points |
| Q2 2026 | -243% | +93 points |
| Q1 2026 | -434% | -128 points |
| Q4 2025 | -577% | -386 points |
| Q3 2025 | -343% | -168 points |
| Q2 2025 | -336% | -130 points |
| Q1 2025 | -306% | -109 points |
| Q4 2024 | -191% | +2125 points |
CXAI's operating margin was −105% last quarter, up 238 points from the same quarter a year ago, near the top of its range since 2023.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC has the edge over CXAI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over CXAI on profitability, with a higher operating margin.
CXAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.7M | +$99K |
| Q4 2025 | -$3.6M | -$937K |
| Q3 2025 | -$2.8M | -$691K |
| Q2 2025 | -$3M | -$1.1M |
| Q1 2025 | -$984K | -$316K |
| Q4 2024 | -$2.7M | +$1.1M |
| Q3 2024 | -$2.1M | +$287K |
| Q2 2024 | -$1.9M | +$4.7M |
INTC has the stronger cash trend. Its trailing FCF is up 258% versus its history, compared with CXAI at down 35%.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC's free cash flow has turned positive after four years mostly in the red: $3.8B over the past year.
CXAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.9% | +230K shares |
| 1 year | +348% | +2M shares |
| 3 years | +1058% | +2.3M shares |
| 5 years | +2040% | +2.4M shares |
CXAI has 3M diluted shares, up 348% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has the edge over CXAI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
CXAI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -0.1x | Net Cash |
CXAI has more cash than debt.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
CXAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.0 | Oversold |
| Stochastic | 2.2 | Oversold |
CXAI's weekly RSI is 30 (oversold) and its Stochastic is 2 (oversold).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CXAI PE vs Technology Sector
| Metric | CXAI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CXAI has no meaningful PE right now: it lost money over the past year.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
CXAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.85 | 26% below |
| 20 week MA | $3.95 | 65% below |
| 50 week MA | $8.80 | 84% below |
| 100 week MA | $31.3 | 96% below |
| 200 week MA | $116.3 | 99% below |
CXAI is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has the edge over CXAI on trend strength, trading above more of its moving averages.
CXAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $511.5 | $498.0 | -2.6% |
| 2022 | $498.0 | $497.5 | -0.1% |
| 2023 | $497.5 | $64.5 | -87% |
| 2024 | $64.5 | $103.5 | +60% |
| 2025 | $103.5 | $16.5 | -84% |
| 2026 YTD | $16.5 | $1.37 | -92% |
CXAI has finished lower in four of the last five years. It's down 92% so far in 2026.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over CXAI on returns for 2026, with the stronger performance.